Top news from MedWatch this week
Miss anything?
BY ELIZABETH MØNSTED JOHANSEN
Tuesday
FDA investigates infection rates for endoscope use – Olympus and Karl Storz recur in reports
Bavarian receives USD 28m order from Janssen
Wednesday
Analyst: Ebola order has positive signal value for Bavarian's investors
EMA sticks to the recommendation of Astrazeneca's covid-vaccine
M&A advisors: "We've never seen such investor interest in this service before"
Thursday
Novo Nordisk tests own mobile app in phase III trial with insulin hope
Lundbeck drug hope moves closer to moment of truth
Danish Health Authority awaits Danish study results before giving verdict on Astrazeneca
Friday
Kesimpta's complicated developmental path has shaped Genmab's approach to partnerships
Novo puts million-dollar figure towards television commercials
.jpg&w=384&q=75)
